Oxolinic Acid
規格
14698-29-4CAS番号
238-750-8EC番号
5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acidIUPAC名
C13H11NO5化学式
261.23 g/mol分子量
oxolinic acid; 14698-29-4; Utibid; Prodoxal; Ossian; Pietil; Acido oxolinico; Acide oxolinique; Acidum oxolinicum; NSC-110364; W 4565; Aqualinic; 5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid; 5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid; 1-Ethyl-6,7-methylenedioxy-4-quinolone-3-carboxylic acid; DTXSID1021089; 1-Ethyl-1,4-dihydro-6,7-methylenedioxy-4-oxo-3-quinolinecarboxylic acid; 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid; L0A22B22FT; CHEBI:138856; 1,3-Dioxolo(4,5-g)quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-; NSC110364; W-4565; DTXCID101089; 1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-; 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid; Acid, Oxolinic; 5-ethyl-8-oxo-(1,3)dioxolo(4,5-g)quinoline-7-carboxylic acid; 5-ethyl-8-oxo-5,8-dihydro(1,3)dioxolo(4,5-g)quinoline-7-carboxylic acid; Oxolinate, Sodium; RefChem:55790; J01MB05; 5-Ethyl-8-oxo-5,8-dihydro (1,3) dioxolo (4,5-g) quinoline-7-carboxylic acid; 238-750-8; Nidantin; Dioxacin; Emyrenil; Prodoxol; Starner; Uroxol; Gramurin; Oksaren; Oxolinic; Ultibid; Uritrate; Urotrate; Oxoboi; Uro-alvar; 5-Ethyl-8-oxo-5,8-dihydro-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid; MFCD00056775; Oxolinic acid impurity B; NCGC00015762-06; Cistopax; Orthurine; Tiurasin; Acido ossolico; CAS-14698-29-4; F3351-0487; Urinox; Acido ossolico [DCIT]; 5-ethyl-8-oxo-5-hydro-2H-1,3-dioxoleno[4,5-g]quinoline-7-carboxylic acid; Acide oxolinique [INN-French]; Acido oxolinico [INN-Spanish]; Acidum oxolinicum [INN-Latin]; CCRIS 6301; HSDB 3243; SR-01000076042; EINECS 238-750-8; S-0208; NSC 110364; BRN 0620635; UNII-L0A22B22FT; Inoxyl; oxolinic-acid; Prodoxol;; Utibid;; Oxolinic acid [USAN:INN:BAN]; Aqualinic (TN); Oxolinic acid CRS; quinolone antibiotic; Prestwick_629; Spectrum_001397; Prestwick0_000193; Prestwick1_000193; Prestwick2_000193; Prestwick3_000193; Spectrum2_000933; Spectrum3_001490; Spectrum4_000073; Spectrum5_001176; Lopac-O-0877; Oxolinic acid (Standard); Epitope ID:768770; 5,8-Dihydro-5-ethyl-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid; OXOLINIC ACID [MI]; Oxolinic acid (USAN/INN); OXOLINIC ACID [INN]; Lopac0_000952; Oprea1_169598; SCHEMBL24445; BSPBio_000145; BSPBio_003079; KBioGR_000625; KBioSS_001877; OXOLINIC ACID [HSDB]; OXOLINIC ACID [USAN]; MLS000028501; DivK1c_000659; SPECTRUM1502030; SPBio_000866; SPBio_002066; OXOLINIC ACID [MART.]; BPBio1_000161; CHEMBL416755; orb1226218; orb1309290; orb3025228; OXOLINIC ACID [WHO-DD]; SCHEMBL29420856; GTPL12999; HMS502A21; HY-B1002R; KBio1_000659; KBio2_001877; KBio2_004445; KBio2_007013; KBio3_002579; MSK5745; NINDS_000659; GLXC-06138; HMS1568H07; HMS1921F12; HMS2092P09; HMS2095H07; HMS3262P06; HMS3712H07; Oxolinic acid, analytical standard; Pharmakon1600-01502030; Oxolinic acid, quinolone antibiotic; SMSSF-0444094; HY-B1002; Tox21_110216; Tox21_202787; Tox21_500952; AC8065; BBL009934; CCG-39666; NSC758177; OXOLINIC ACID [EP MONOGRAPH]; s4537; SBB012469; STK801351; AKOS000282622; Tox21_110216_1; CS-4499; DB13627; EBC-380044; LP00952; NSC-758177; SDCCGSBI-0050926.P004; 5-ETHYL-8-OXO-2H,5H,8H-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBOXYLIC ACID; IDI1_000659; NCGC00015762-01; NCGC00015762-02; NCGC00015762-03; NCGC00015762-04; NCGC00015762-05; NCGC00015762-07; NCGC00015762-08; NCGC00015762-09; NCGC00015762-10; NCGC00015762-11; NCGC00015762-13; NCGC00015762-17; NCGC00093361-02; NCGC00093361-03; NCGC00093361-04; NCGC00093361-05; NCGC00260333-01; NCGC00261637-01; AS-12087; CN-66706; SMR000058314; ST067125; SY066716; SBI-0050926.P003; DB-042865; EU-0100952; NS00010598; O9458; VU0243182-3; D02301; O 0877; WLN: T C566 DO FO JN MV EHJ J2 LVQ; F242886; Q287840; SR-01000076042-1; SR-01000076042-4; SR-01000076042-6; BRD-K73394555-001-08-6; BRD-K73394555-237-01-1; 5-Ethyl-5,3-dioxolo[4,5-g]quinoline-7-carboxylic acid; 1-Ethyl-1,7-methylenedioxy-4-oxo-3-quinolinecarboxylic acid; Oxolinic acid, European Pharmacopoeia (EP) Reference Standard; 1,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-; 1.4-Dihydro-1-ethyl-6,7-methylenedioxy-4-oxoquinoline-3-carboxylic acid; 5-ETHYL-5,8-DIHYDRO-8-OXO(1,3)DIOXOLO(4,5-G)QUINOLINE-7-CARBOXYLIC ACID; 5-Ethyl-8-oxo-5,8-dihydro-2H-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid; 5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid #; W-4565; 5,8-Dihydro-5-ethyl-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid; 10-ethyl-13-oxo-4,6-dioxa-10-azatricyclo[7.4.0.0(3),]trideca-1,3(7),8,11-tetraene-12-carboxylic acid; InChI=1/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17別名
